|
|
ossification
|
GO:0001503 |
216 |
0.833
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.775
|
|
|
|
regulation of chromatin silencing
|
GO:0031935 |
2 |
0.771
|
|
|
|
natural killer cell differentiation
|
GO:0001779 |
21 |
0.740
|
Mouse |
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.722
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.696
|
Mouse |
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.659
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.617
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.593
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.565
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.530
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.499
|
|
|
|
monocyte differentiation
|
GO:0030224 |
9 |
0.498
|
Mouse |
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.491
|
|
|
|
histone h4 deacetylation
|
GO:0070933 |
4 |
0.488
|
|
|
|
fibroblast proliferation
|
GO:0048144 |
35 |
0.487
|
Mouse |
|
|
trophectodermal cell differentiation
|
GO:0001829 |
21 |
0.481
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.474
|
Mouse |
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.451
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.443
|
Mouse |
|
|
gland development
|
GO:0048732 |
330 |
0.436
|
|
|
|
protein deacetylation
|
GO:0006476 |
32 |
0.429
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.411
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.406
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.397
|
Mouse |
|
|
skeletal system development
|
GO:0001501 |
356 |
0.396
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.394
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.380
|
Mouse |
|
|
germ cell development
|
GO:0007281 |
185 |
0.376
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.374
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.357
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.349
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.345
|
Mouse |
|
|
placenta development
|
GO:0001890 |
140 |
0.345
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.345
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.333
|
Mouse |
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.322
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.320
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.306
|
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
26 |
0.301
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.284
|
Mouse |
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.278
|
Mouse |
|
|
heart contraction
|
GO:0060047 |
93 |
0.276
|
Mouse |
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.265
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.262
|
|
|
|
embryonic process involved in female pregnancy
|
GO:0060136 |
7 |
0.258
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.252
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.245
|
|
|
|
cellular response to radiation
|
GO:0071478 |
28 |
0.244
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.232
|
|
|
|
regulation of transcription during meiosis
|
GO:0051037 |
1 |
0.226
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.225
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.224
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.219
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.216
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.212
|
|
|
|
natural killer cell activation
|
GO:0030101 |
44 |
0.212
|
Mouse |
|
|
negative regulation of chromatin silencing
|
GO:0031936 |
1 |
0.209
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.209
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.198
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.191
|
Mouse |
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.189
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.186
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.184
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.183
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.182
|
|
|
|
histone deacetylation
|
GO:0016575 |
26 |
0.180
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.177
|
Mouse |
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.176
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.171
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.171
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.169
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.169
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.169
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.165
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.161
|
Mouse |
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.160
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.157
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.156
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.155
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.155
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.154
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.152
|
|
|
|
negative regulation of gene expression epigenetic
|
GO:0045814 |
15 |
0.149
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.149
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.147
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.143
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.142
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.142
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.142
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.140
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.137
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.136
|
|
|
|
viral transcription
|
GO:0019083 |
3 |
0.136
|
Human |
|
|
male meiosis
|
GO:0007140 |
37 |
0.136
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.132
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.131
|
|
|
|
nuclear transcribed mrna poly a tail shortening
|
GO:0000289 |
7 |
0.131
|
|
|
|
mrna catabolic process
|
GO:0006402 |
22 |
0.129
|
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.127
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.126
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.126
|
Mouse |
|
|
chromatin silencing
|
GO:0006342 |
15 |
0.125
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.123
|
|
|
|
nuclear transcribed mrna catabolic process deadenylation dependent decay
|
GO:0000288 |
12 |
0.123
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.122
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.121
|
Fly |
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.120
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.120
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.120
|
|
|
|
histone h4 k12 acetylation
|
GO:0043983 |
2 |
0.119
|
|
|
|
chromatin silencing at rdna
|
GO:0000183 |
3 |
0.119
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.118
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.117
|
Mouse |
|
|
organelle fission
|
GO:0048285 |
170 |
0.116
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.115
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.114
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.114
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.113
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.111
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.110
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.109
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.105
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.105
|
|
|
|
viral gene expression
|
GO:0019080 |
3 |
0.104
|
Human |
|
|
enucleate erythrocyte differentiation
|
GO:0043353 |
8 |
0.104
|
|
|
|
stem cell fate specification
|
GO:0048866 |
3 |
0.103
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.103
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.101
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.101
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.101
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.100
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
47 |
0.100
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.100
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.100
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.099
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.098
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.095
|
Mouse |
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.094
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.094
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.093
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
28 |
0.092
|
|
|
|
granulocyte differentiation
|
GO:0030851 |
17 |
0.090
|
Mouse |
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.090
|
Human |
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.089
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.089
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.088
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.088
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.087
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.087
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.085
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.085
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.083
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.083
|
|
|
|
regulation of viral transcription
|
GO:0046782 |
3 |
0.083
|
Human |
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
34 |
0.083
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.082
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.082
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.082
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.081
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.079
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.079
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.079
|
|
|
|
protein deacylation
|
GO:0035601 |
36 |
0.079
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.078
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.077
|
|
|
|
blastocyst formation
|
GO:0001825 |
33 |
0.077
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.076
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.074
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.074
|
|
|
|
transdifferentiation
|
GO:0060290 |
1 |
0.074
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.074
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.074
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.074
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.073
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.072
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.072
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.072
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.072
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.071
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.070
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.070
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.069
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.068
|
Mouse |
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.068
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.067
|
|
|
|
positive regulation of fat cell differentiation
|
GO:0045600 |
32 |
0.067
|
|
|
|
post anal tail morphogenesis
|
GO:0036342 |
23 |
0.066
|
Mouse |
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.065
|
|
|
|
positive regulation of histone modification
|
GO:0031058 |
28 |
0.064
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.064
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.064
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.064
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.063
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.063
|
|
|
|
ribonucleoprotein complex subunit organization
|
GO:0071826 |
28 |
0.062
|
|
|
|
dna damage checkpoint
|
GO:0000077 |
26 |
0.062
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.060
|
|
|
|
regulation of peptidyl lysine acetylation
|
GO:2000756 |
22 |
0.060
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.060
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.059
|
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
31 |
0.059
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.059
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.059
|
|
|
|
erbb signaling pathway
|
GO:0038127 |
32 |
0.059
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.059
|
|
|
|
modification of morphology or physiology of other organism involved in symbiotic interaction
|
GO:0051817 |
16 |
0.059
|
Human |
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.058
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.058
|
|
|
|
negative regulation of gene silencing
|
GO:0060969 |
2 |
0.058
|
|
|
|
response to superoxide
|
GO:0000303 |
16 |
0.056
|
|
|
|
positive regulation of myeloid cell differentiation
|
GO:0045639 |
43 |
0.056
|
|
|
|
viral life cycle
|
GO:0019058 |
36 |
0.055
|
Human |
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.055
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.055
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.055
|
|
|
|
regulation of protein deacetylation
|
GO:0090311 |
17 |
0.054
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.054
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.054
|
|
|
|
rna catabolic process
|
GO:0006401 |
29 |
0.054
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0043618 |
8 |
0.053
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.053
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.052
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.052
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.052
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.051
|
|
|
|
definitive hemopoiesis
|
GO:0060216 |
20 |
0.050
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.050
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.050
|
|
|
|
cytoplasmic mrna processing body assembly
|
GO:0033962 |
6 |
0.049
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.049
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.048
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.048
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.047
|
Human |
|
|
ear development
|
GO:0043583 |
200 |
0.047
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.047
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.047
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.047
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.047
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.046
|
Mouse |
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.046
|
|
|
|
germline cell cycle switching mitotic to meiotic cell cycle
|
GO:0051729 |
1 |
0.046
|
|
|
|
negative regulation of hormone biosynthetic process
|
GO:0032353 |
4 |
0.045
|
|
|
|
telomere maintenance
|
GO:0000723 |
19 |
0.045
|
|
|
|
viral process
|
GO:0016032 |
41 |
0.045
|
Human |
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.045
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.044
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.044
|
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.044
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.044
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.044
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.044
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.044
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.044
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.043
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.043
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
33 |
0.043
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.043
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.043
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.043
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.043
|
|
|
|
myelination in peripheral nervous system
|
GO:0022011 |
19 |
0.043
|
|
|
|
regulation of transcription involved in g1 s transition of mitotic cell cycle
|
GO:0000083 |
3 |
0.043
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.042
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.042
|
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
30 |
0.042
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.042
|
|
|
|
histone lysine demethylation
|
GO:0070076 |
13 |
0.042
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.042
|
Human |
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.042
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.041
|
|
|
|
response to osmotic stress
|
GO:0006970 |
21 |
0.041
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.041
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
56 |
0.041
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.041
|
|
|
|
mrna transcription from rna polymerase ii promoter
|
GO:0042789 |
4 |
0.041
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.041
|
|
|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.040
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0036003 |
3 |
0.040
|
|
|
|
response to epidermal growth factor
|
GO:0070849 |
4 |
0.040
|
|
|
|
negative regulation of alcohol biosynthetic process
|
GO:1902931 |
4 |
0.040
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.040
|
|
|
|
signal transduction involved in mitotic dna damage checkpoint
|
GO:1902402 |
3 |
0.040
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.039
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.039
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.039
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.039
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.039
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.039
|
|
|
|
modification of morphology or physiology of other organism
|
GO:0035821 |
18 |
0.039
|
Human |
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.039
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.038
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.038
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.038
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.038
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.038
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.038
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.038
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.038
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.038
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.037
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.037
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.037
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.037
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.037
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
52 |
0.037
|
Human |
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.037
|
|
|
|
embryonic camera type eye development
|
GO:0031076 |
36 |
0.037
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.037
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.037
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.037
|
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.036
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.036
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.036
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.036
|
|
|
|
male meiosis i
|
GO:0007141 |
16 |
0.036
|
|
|
|
regulation of nuclear cell cycle dna replication
|
GO:0033262 |
2 |
0.036
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.035
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.035
|
|
|
|
regulation of histone deacetylation
|
GO:0031063 |
12 |
0.035
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.035
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.035
|
|
|
|
positive regulation of histone h3 k9 methylation
|
GO:0051574 |
4 |
0.035
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.035
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.035
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.035
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.034
|
|
|
|
regulation of histone h3 k9 methylation
|
GO:0051570 |
8 |
0.034
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.034
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.034
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.034
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.034
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.034
|
Mouse |
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.034
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.034
|
|
|
|
dna dependent dna replication
|
GO:0006261 |
24 |
0.034
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.033
|
|
|
|
regulation of transcription by chromatin organization
|
GO:0034401 |
0 |
0.033
|
|
|
|
response to purine containing compound
|
GO:0014074 |
28 |
0.033
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.033
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.033
|
|
|
|
rna localization
|
GO:0006403 |
23 |
0.033
|
|
|
|
maintenance of chromatin silencing
|
GO:0006344 |
2 |
0.033
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.033
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.033
|
|
|
|
positive regulation of osteoclast differentiation
|
GO:0045672 |
15 |
0.033
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.033
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.033
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.032
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.032
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.032
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.032
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.032
|
|
|
|
histone demethylation
|
GO:0016577 |
13 |
0.031
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.031
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
7 |
0.031
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.031
|
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
69 |
0.031
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.031
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.030
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.030
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.030
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.030
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.030
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.030
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.030
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.030
|
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
33 |
0.029
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.029
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.029
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.029
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.029
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.029
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.029
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.029
|
Mouse |
|
|
cellular response to epidermal growth factor stimulus
|
GO:0071364 |
4 |
0.028
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.028
|
|
|
|
mrna transcription
|
GO:0009299 |
4 |
0.028
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.028
|
|
|
|
regulation of mrna stability
|
GO:0043488 |
23 |
0.028
|
|
|
|
histone h3 k9 dimethylation
|
GO:0036123 |
4 |
0.028
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.028
|
|
|
|
negative regulation of transcription from rna polymerase i promoter
|
GO:0016479 |
2 |
0.028
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.028
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.028
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.028
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.028
|
|
|
|
cellular response to gamma radiation
|
GO:0071480 |
4 |
0.028
|
|
|
|
negative regulation of viral transcription
|
GO:0032897 |
3 |
0.028
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.028
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.028
|
|
|
|
negative regulation of hormone metabolic process
|
GO:0032351 |
4 |
0.028
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.028
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.028
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.027
|
|
|
|
regulation of osteoclast differentiation
|
GO:0045670 |
36 |
0.027
|
|
|
|
signal transduction involved in mitotic dna integrity checkpoint
|
GO:1902403 |
3 |
0.027
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.027
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.027
|
|
|
|
rna 3 end processing
|
GO:0031123 |
20 |
0.027
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.027
|
|
|
|
regulation of nuclear transcribed mrna poly a tail shortening
|
GO:0060211 |
4 |
0.027
|
|
|
|
cell cycle switching mitotic to meiotic cell cycle
|
GO:0051728 |
1 |
0.027
|
|
|
|
regulation of dna templated transcription in response to stress
|
GO:0043620 |
9 |
0.027
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.027
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.027
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.026
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.026
|
|
|
|
regulation of transcription from rna polymerase i promoter
|
GO:0006356 |
6 |
0.026
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.026
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.026
|
|
|
|
somatotropin secreting cell development
|
GO:0060133 |
2 |
0.026
|
|
|
|
spongiotrophoblast layer development
|
GO:0060712 |
15 |
0.026
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.026
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.026
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.026
|
|
|
|
ectodermal cell differentiation
|
GO:0010668 |
3 |
0.026
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.025
|
|
|
|
regulation of gene silencing
|
GO:0060968 |
7 |
0.025
|
Fly |
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.025
|
|
|
|
regulation of autophagy
|
GO:0010506 |
30 |
0.025
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.025
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.025
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.025
|
|
|
|
response to uv
|
GO:0009411 |
44 |
0.025
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.025
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.025
|
Mouse |
|
|
macromolecule deacylation
|
GO:0098732 |
37 |
0.025
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.025
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.025
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
24 |
0.025
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.024
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.024
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.024
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.024
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.024
|
Mouse |
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.024
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.024
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.024
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.024
|
|
|
|
regulation of ketone biosynthetic process
|
GO:0010566 |
2 |
0.024
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.024
|
|
|
|
negative regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903051 |
22 |
0.023
|
|
|
|
lung cell differentiation
|
GO:0060479 |
30 |
0.023
|
|
|
|
signal transduction involved in dna damage checkpoint
|
GO:0072422 |
3 |
0.023
|
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.023
|
|
|
|
regulation of mrna processing
|
GO:0050684 |
41 |
0.023
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.023
|
|
|
|
nerve development
|
GO:0021675 |
67 |
0.023
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.023
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.023
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.023
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.023
|
|
|
|
positive regulation of nuclear transcribed mrna poly a tail shortening
|
GO:0060213 |
4 |
0.022
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.022
|
|
|
|
adipose tissue development
|
GO:0060612 |
25 |
0.022
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.022
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.022
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.022
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.022
|
|
|
|
negative regulation of dna replication
|
GO:0008156 |
4 |
0.022
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.022
|
|
|
|
lymphocyte anergy
|
GO:0002249 |
4 |
0.022
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.022
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.022
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.022
|
|
|
|
positive chemotaxis
|
GO:0050918 |
18 |
0.022
|
|
|
|
heart valve development
|
GO:0003170 |
23 |
0.022
|
|
|
|
neuroepithelial cell differentiation
|
GO:0060563 |
37 |
0.022
|
|
|
|
regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032434 |
40 |
0.022
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.022
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.022
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.021
|
|
|
|
negative regulation of leukocyte proliferation
|
GO:0070664 |
46 |
0.021
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.021
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.021
|
|
|
|
positive regulation of myeloid leukocyte differentiation
|
GO:0002763 |
26 |
0.021
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.021
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.021
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.021
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.021
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.021
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.021
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.021
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.021
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.021
|
|
|
|
histone h4 acetylation
|
GO:0043967 |
10 |
0.021
|
|
|
|
protein dealkylation
|
GO:0008214 |
13 |
0.020
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.020
|
|
|
|
negative regulation of exocytosis
|
GO:0045920 |
12 |
0.020
|
|
|
|
regulation of antimicrobial humoral response
|
GO:0002759 |
3 |
0.020
|
|
